The vaccine appears to prime the immune system in a powerful, nonspecific way, enhancing cancer treatment outcomes. If confirmed, the discovery could lead to a universal cancer vaccine and transform oncology care.
Results from this phase showed 88% of mice rejected pancreatic tumors, 75% rejected breast tumors, and 69% rejected melanoma. All tumor-free mice also resisted further cancer spread.
Researchers believe they have developed the first dedicated blood test to diagnose chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis (ME), which has the potential to be a game-changer for millions around the globe who suffer from the debilitating condition.
In trials, in 708 women, when combined with hormone therapy, the drug doubled the time the cancer took to grow, from 3.6 months to 7.3 months, and shrank tumours in 23% of patients.